Genexi logo
Website

Genexi (GEN)

ICO

Genexi accelerates the transition of biotech projects from research to the market.

IMPORTANT: By investing in this business you agree to ourDisclaimer. All information including our rating, is provided merely for informational purposes. CryptoTotem does not provide investment advice.

Overview

Project industryScience & Research
Product typeEcosystem
WhitepaperGenexi White Paper Open

What is Genexi

Genexi is a biotech accelerator that operates as a Platform and a Foundation focusing on Hi-Tech Bio&Med research and drug development. Genexi combines the expertise of specialists in the biotech industry to create an ecosystem for pharmaceutical companies of different levels of operation from around the world. Genexi Foundation will use its expertise and funds to handpick auspicious biotech startup projects for investment and research grant awarding. Genexi Foundation will also provide research, business development and marketing support to these projects to ensure their further development. Genexi ecosystem will allow a wide range of participants to join the development; aside from the general involvement of every member into the supply chain, GENEXI will provide the marketplace for side services, such as research centers, laboratories and institutes.

Details

Pre-sales: May 01, 2018 - May 31, 2018
Public sales: Jun 01, 2018 - Aug 31, 2018
Token supply: 8,400,000,000
Soft cap: 20,000,000USD (fiat)
Hard cap: 70,000,000 USD(fiat)

Legal

Registration country: Russian Federation

Token info

Ticker: GEN
Type: Utility-token
Token price in USD: 1 GEN = 0.01 USD
Accepted currencies: ETH
Bonus program:
Pre-Sale Round: 20% bonus
Token Sale Round 1: 17% bonus
Token Sale Round 2: 9% bonus
Token Sale Round 3: 5% bonus
Token Sale Round 4: 2% bonus
Token distribution:
70% - Public Distribution
10% - Long-term Foundation Budget
15% - Founders, Team
5% - Advisors and Early Contributors
Funds allocation:
60% - Community Grants, Partnerships & Software Development
20% - Marketing and Business Development
10% - Operational Expenses
5% - Legal Expenses
5% - Misc and Unexpected

Genexi Roadmap

1
2014

Primary Scientific and Medical Research.

2
Q1 2017

GENEXI Establishment.

3
Q3 2017

Ecosystem and Platform Development.

4
Q1 2018

Low Level Design Launch.

5
Q3 2018

Ecosystem Alpha Version Testing.

6
Q4 2018

Smart-Contract Development and Testing. Grant Application Program Launch.

7
H1 2019

Ecosystem Complete Version Launch.

8
H2 2019

Official Public GENEXI Accelerator Report.

9
2020

Further Ecosystem Development and Scaling.

Project team

Katrina Arden
Katrina Arden
Escrow
Katrina Arden linkedin
Alexey Kirillov
Alexey Kirillov
Co-Founder, COo
Roman Gilvanov
Roman Gilvanov
Managing Director
Roman Gilvanov linkedin
Sergey Tiurin
Sergey Tiurin
Head of Medical Research
Andrew Zharkov
Andrew Zharkov
Head of Finance
Bogdan Stepanov
Bogdan Stepanov
Head of Business Development
Bogdan Stepanov linkedin
Anton Sklovets
Anton Sklovets
Head of Research
Daria Goriychuk
Daria Goriychuk
Head of HR
Daria Goriychuk linkedin
Alexander Novoselov
Alexander Novoselov
Biotech Analyst
Anton Nizhenkov
Anton Nizhenkov
Investment Analyst
Anton Nizhenkov linkedin
Dennis Sarkar
Dennis Sarkar
Ecosystem Developer
Dennis Sarkar linkedin
Jacques Miabouna
Jacques Miabouna
Strategy Consultant
Anastasia Verbitskaya
Anastasia Verbitskaya
SMM
Anastasia Verbitskaya linkedin
Denis Baldakov
Denis Baldakov
Community Manager
Denis Baldakov linkedin
Artem Targosh
Artem Targosh
Community manager
Artem Targosh linkedin
Anna Rafaelli
Anna Rafaelli
Chief Editor
Anna Rafaelli facebook
Inna Leonova
Inna Leonova
Graphic Designer
Inna Leonova linkedin
Anna Fursova
Anna Fursova
PR Manager
Anna Fursova facebook
Margarita Ilina
Margarita Ilina
PR Manager
Egor Stepanov
Egor Stepanov
Head of IT
Egor Stepanov linkedin
Alexander Abarevich
Alexander Abarevich
Technical Support Lead
Alexander Abarevich linkedin

Advisors

Anti Danilevski
Anti Danilevski
ICO advisor
Anti Danilevski linkedin
Malcolm Tan
Malcolm Tan
Advisor
Malcolm Tan linkedin
Roel Wolfert
Roel Wolfert
Advisor
Roel Wolfert linkedin
Philip McMaster
Philip McMaster
Advisor
Philip McMaster linkedin
Richard O'Rourke
Richard O'Rourke
Advisor
Richard O'Rourke linkedin
Manuel Rimarachin
Manuel Rimarachin
Advisor
Manuel Rimarachin linkedin

Social media

Genexi web-siteGenexi MediumGenexi TelegramGenexi X (Twitter)Genexi Facebook

Leave a Reply

Your email address will not be published. Required fields are marked *

Sponsored Crypto Projects

Newly Published